YM BioSciences (YM.TO) Completes Merger with Cytopia Limited (CYT.AX)
2/1/2010 7:11:56 AM
More...
|
YM BioSciences (YM.TO) Announces Result of Cytopia Limited (CYT.AX) Shareholder Vote
1/12/2010 8:48:15 AM
More...
|
YM BioSciences (YM.TO) Offer For Cytopia Limited (CYT.AX) Approved To Proceed To Shareholder Vote By Australian Court
12/10/2009 11:23:32 AM
More...
|
YM BioSciences (YM.TO) Reports First Patient In Phase I/Ii Trial Of Jak1/Jak2 Inhibitor, Cyt387 Enrolled By Cytopia Limited (CYT.AX)
11/24/2009 8:51:41 AM
More...
|
YM BioSciences (YM.TO) Announces $14.05 Million Offer for Cytopia Limited (CYT.AX), an Australian Cancer-Focused Development Company
10/6/2009 6:49:53 AM
More...
|
Cytopia Limited (CYT.AX)'s CYT387 Receives FDA Clearance to Start US Clinical Trials
9/4/2009 8:36:13 AM
More...
|
Cytopia Limited (CYT.AX) Lodges IND for JAK2 Inhibitor CYT387
6/23/2009 8:58:46 AM
More...
|
Cytopia Limited (CYT.AX): Oral VDA CYT997 - Phase I Clinical Trial Presentation at American Society of Clinical Oncology
5/29/2009 10:47:06 AM
More...
|
Cytopia Limited (CYT.AX) Presentation on VDA CYT997 at American Association for Cancer Research Conference
4/16/2009 11:32:28 AM
More...
|
Cytopia Limited (CYT.AX) Letter to Progen Industries Limited (PGLA) Shareholders
2/25/2009 9:50:08 AM
More...
|
|